Global Substance Abuse Treatment Market Review and Forecast to 2030: Alcohol Addiction Commanded the Largest Market Share of 34.27% in 2022, Followed by Nicotine Addiction
Company Logo
Company Logo

Global Substance Abuse Treatment Market

Global Substance Abuse Treatment Market
Global Substance Abuse Treatment Market

Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Global Substance Abuse Treatment Market by Substance Abuse Type (Alcohol Addiction, Cocaine, Marijuana), Product (Behavioral Treatment, Drugs), Treatment Option, Distribution Channel - Cumulative Impact of High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.

The Global Substance Abuse Treatment Market was estimated at USD 6,432.51 million in 2022, USD 7,044.96 million in 2023, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.95% to reach USD 13,743.20 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and high inflation is expected to have significant long-term effects on the Global Substance Abuse Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic.

Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of high inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage

This research report categorizes the Global Substance Abuse Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

  • Based on Substance Abuse Type, the market is studied across Alcohol Addiction, Cocaine, Marijuana, and Nicotine Addiction. The Alcohol Addiction commanded largest market share of 34.27% in 2022, followed by Nicotine Addiction.

  • Based on Product, the market is studied across Behavioral Treatment and Drugs. The Drugs is further studied across Acamprosate, Buprenorphine, Bupropion, Disulfiram, Methadone, Naltrexone, and Varenicline. The Behavioral Treatment commanded largest market share of 58.38% in 2022, followed by Drugs.

  • Based on Treatment Option, the market is studied across Group Counseling, In-patient Treatment, Individualized Drug Counseling, Long-Term Residential Treatment, Outpatient Treatment Programs, and Short-Term Residential Treatment. The Group Counseling commanded largest market share of 33.91% in 2022, followed by Outpatient Treatment Programs.

  • Based on Distribution Channel, the market is studied across Hospital Pharmacies and Retail Pharmacies & Drug Stores. The Hospital Pharmacies commanded largest market share of 32.71% in 2022, followed by Retail Pharmacies & Drug Stores.

  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Europe, Middle East & Africa commanded largest market share of 44.63% in 2022, followed by Americas.